(Q44105527)

29 November 2017

Hyperhomocysteinemia and venous thromboembolism: a risk factor more prevalent in the elderly and in idiopathic cases (English)

1 reference

29 November 2017

venous thromboembolism

1 reference

Philippe Hainaut

1

1 reference

29 November 2017

Carine Jaumotte

2

1 reference

29 November 2017

David Verhelst

3

1 reference

29 November 2017

Pierre Wallemacq

4

1 reference

29 November 2017

Jean-Luc Gala

5

1 reference

29 November 2017

Edith Lavenne

6

1 reference

29 November 2017

Michel Heusterspreute

7

1 reference

29 November 2017

Francis Zech

8

1 reference

29 November 2017

Maurice Moriau

9

1 reference

29 November 2017

1 April 2002

1 reference

29 November 2017

1 reference

29 November 2017

106

1 reference

29 November 2017

2

1 reference

29 November 2017

121-125

1 reference

Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900096-8

7 January 2021

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900096-8

7 January 2021

Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: more evidence from a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900096-8

7 January 2021

Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900096-8

7 January 2021

Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900096-8

7 January 2021

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900096-8

7 January 2021

Prevalence of activated protein C resistance and analysis of clinical profile in thromboembolic patients. A Belgian prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900096-8

7 January 2021

Mutation in blood coagulation factor V associated with resistance to activated protein C.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900096-8

7 January 2021

High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900096-8

7 January 2021

Relationship between homocysteine and thrombotic disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900096-8

7 January 2021

10.1016/S0049-3848(02)00096-8

Identifiers

DOI

1 reference

29 November 2017

1 reference